Abdominal Scar Improvement in Microsurgical Breast Reconstruction

Description

Microsurgical breast reconstruction is most commonly performed with free abdominal flaps, which leave a long transverse lower abdominal scar. Due to tension across the incision, these scars frequently widen and hypertrophy. Hence, modalities that can reduce this tendency, thus, improving scar appearance are desirable. Here, we wish to investigate the impact of the Neodyne embrace device on postoperative abdominal scar appearance. The proposed study is novel in that it is the first RCT investigating the effect of the embrace device on scar appearance in the context of microsurgical breast reconstruction.

Conditions

Cicatrix, Breast Reconstruction

Talk to us

Study Overview

On this page

Study Details

Study overview

Microsurgical breast reconstruction is most commonly performed with free abdominal flaps, which leave a long transverse lower abdominal scar. Due to tension across the incision, these scars frequently widen and hypertrophy. Hence, modalities that can reduce this tendency, thus, improving scar appearance are desirable. Here, we wish to investigate the impact of the Neodyne embrace device on postoperative abdominal scar appearance. The proposed study is novel in that it is the first RCT investigating the effect of the embrace device on scar appearance in the context of microsurgical breast reconstruction.

Abdominal Scar Improvement in Microsurgical Breast Reconstruction

Abdominal Scar Improvement in Microsurgical Breast Reconstruction

Condition
Cicatrix
Intervention / Treatment

-

Contacts and Locations

Stanford

Stanford University Medical Center, Stanford, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Female Subjects who have undergone unilateral/bilateral microsurgical breast reconstruction with free abdominal flaps within approximately 1 week (4-8 days) prior to study participation.
  • 2. Appearance of subject's incision is aesthetically similar across length of incision
  • 3. Age \>18
  • 4. Subject has the ability to read and comprehend as required by the protocol and the informed consent.
  • 5. Subject must be able to provide written informed consent prior to participation in the study.
  • 1. Subjects with a history of collagen vascular disease, cutis laxica, connective tissue disease, psoriasis, or lupus.
  • 2. Subjects diagnosed with scleroderma.
  • 3. Subjects with known adverse reactions to steri-strip tapes, medical tapes, or adhesives.
  • 4. Subjects with oozing, dehiscence, non-closed/healed incisions at time of first application.
  • 5. Subjects with inability to maintain adequate care of incision.
  • 6. Subjects with a weight loss of \> 100 lbs within 6 months from date of surgery.
  • 7. Subjects who currently smoke.
  • 8. Subjects taking steroid therapy (systemic or inhaled) within 2 months from date of study enrollment.
  • 9. Subject does not qualify for the study in the opinion of the investigators.

Ages Eligible for Study

18 Years to 89 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Arash Momeni, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2025-10-31